Paharik, Alexandra E.Schreiber, Henry L.Spaulding, CaitlinDodson, Karen W.Hultgren, Scott J.2018-01-182017Paharik, Alexandra E., Henry L. Schreiber, Caitlin N. Spaulding, Karen W. Dodson, and Scott J. Hultgren. 2017. “Narrowing the spectrum: the new frontier of precision antimicrobials.” Genome Medicine 9 (1): 110. doi:10.1186/s13073-017-0504-3. http://dx.doi.org/10.1186/s13073-017-0504-3.http://nrs.harvard.edu/urn-3:HUL.InstRepos:34652011Editorial summary Antibiotics have become the standard of care for bacterial infections. However, rising rates of antibiotic-resistant infections are outpacing the development of new antimicrobials. Broad-spectrum antibiotics also harm beneficial microbial communities inhabiting humans. To combat antibiotic resistance and protect these communities, new precision antimicrobials must be engineered to target specific pathogens.en-USJournal Article2018-01-1810.1186/s13073-017-0504-3